echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > The lower the level of T3 and FT3, the more severe the cognitive impairment in stroke patients? Shijiazhuang People’s Hospital publishes important correlation analysis丨Stroke "Miscellaneous" Talk · Issue 3

    The lower the level of T3 and FT3, the more severe the cognitive impairment in stroke patients? Shijiazhuang People’s Hospital publishes important correlation analysis丨Stroke "Miscellaneous" Talk · Issue 3

    • Last Update: 2021-06-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "Chinese Stroke Journal" is a high-level academic journal of the medical profession headed by the Ministry of Science and Technology of the People's Republic of China, sponsored by the Chinese Institute of Science and Technology Information, and undertaken by the Chinese Stroke Society.

    In order to strengthen the medical information exchange in the field of cerebrovascular diseases, improve the academic level of medicine, and serve the vast number of medical technology and health workers, the "Chinese Journal of Stroke" and the Yimaitong platform jointly launched a series of columns-"Stroke "Miscellaneous" Talks".

    This column selects the high-quality content related to stroke in each issue of the Chinese Journal of Stroke, adapts it, and publishes it on the "Yimaitong Neurology" public account.
    We look forward to learning and discussing stroke-related diseases with you! This article is organized: Text/Tang Jiu (Chinese Stroke Journal) Note: This article has been officially authorized by the "Chinese Stroke Journal", please do not reprint without authorization.

    The original source of the article: Li Hong, Ma Jiang, Shi Wanying, et al.
    Study on the correlation between thyroid hormone levels and cognitive function during stroke recovery period[J].
    Chinese Journal of Stroke, 2021, 16(05): 482-486.
    Literature download Link: http:// Review of previous issues ↓↓↓ Issue 1: Why is it said that playing games can cure cognitive impairment? This review tells you the second issue: How to build a high-quality biobank of cerebrovascular diseases? The Temple of Heaven experience is here! A large amount of literature shows that 20% to 80% of patients with stroke will have varying degrees of cognitive impairment, which seriously affects the quality of life of patients.

    And early exploration of the influencing factors of cognitive function after stroke has important clinical significance in restoring patients' cognitive function and improving the prognosis.

    At present, some scholars have found that, in addition to impairing neurological function and undermining patients' cognition, stroke can also cause hypothalamic-pituitary-thyroid axis disorders, causing abnormal levels of thyroid hormones and affecting cognitive function.

    To clarify the correlation between the levels of triiodothyronine (T3) and free triiodothyronine (FT3) in thyroid hormones and the cognitive function of stroke patients, Li Hong, Ma Jiang, Shi Wanying and other scholars from Shijiazhuang People’s Hospital Published important correlation studies in our journal to explore potential clinical predictive indicators that may affect cognitive function, and provide references for cognitive function rehabilitation.

     Inclusion: The author prospectively included 210 patients in the recovery phase of stroke who were admitted to the Department of Rehabilitation Medicine of Shijiazhuang People's Hospital from December 2018 to January 2020 based on the following review criteria.

    Inclusion criteria: ①age>50 years; ②years of education ≥8 years; ③conform to the diagnostic criteria revised in the 4th National Cerebrovascular Disease Conference, confirmed by CT or MRI ④Stroke onset is 2 weeks to 6 months, and vital signs are stable ⑤The first onset was a unilateral hemispheric lesion, including cerebral infarction and cerebral hemorrhage.

    Exclusion criteria: ①Subarachnoid hemorrhage and TIA ②Combined with severe heart, lung, liver, kidney and other organ dysfunction ③Severe mental, psychological, visual, auditory comprehension and aphasia ④Previous thyroid disease ⑤Coma, unconsciousness, Dementia and cognitive impairment before stroke ⑥ complicated with severe infection ⑦ long-term use of glucocorticoid or amiodarone drugs.

     Research methods Collect baseline data: record the patient's baseline data, including demographic information (age, gender, education level), past history (hypertension, diabetes, hyperlipidemia, smoking, drinking), hospital admission NIHSS score, stroke type , The side of the lesion and the course of stroke.

     Grouping method: According to whether the patients have cognitive impairment, they are divided into the cognitive impairment group and the non-cognitive impairment group.

    The patient’s cognitive function is assessed using MMSE.
    MMSE includes seven aspects: time orientation, place orientation, immediate memory, attention and calculation, delayed memory, language, and visual spatial structure.
    There are 30 questions in total, each with 1 point, totaling 30.
    The higher the score, the better the cognitive function; MMSE is assessed as cognitive impairment with illiteracy ≤ 17 points, elementary school culture ≤ 20 points, middle school culture ≤ 22 points, and university or higher culture ≤ 23 points.  Hematology test: standard serum samples are made by collecting cubital venous blood in the early morning on the second day of admission and in a quiet state, using automatic immunoassay analyzer and thyroid hormone detection reagents to detect T3, T4, FT3, FT4) and thyroid stimulating hormone (TSH) level.

     Statistical methods: Multiple linear regression was used to analyze the relationship between the levels of thyroid hormones and MMSE scores in patients with stroke recovery.

    The difference was statistically significant when P<0.
    05.

     Comparison of baseline data of study results: 210 patients with an average age of 59.
    97±7.
    12 years old were finally included.
    Among them, 146 were in the cognitive impairment group and 64 were in the non-cognitive impairment group.
    The incidence of cognitive impairment during stroke recovery was 69.
    52.
    %.

    The age and NIHSS scores of the cognitive impairment group were higher than those of the non-cognitive impairment group, and the T3 and FT3 levels were lower than those of the non-cognitive impairment group.
    The difference was statistically significant.

     There was no statistically significant difference between the two groups of patients in gender, education level, past history, stroke type, side of the lesion, and stroke course.

    Multiple linear regression analysis: Serum T3 and FT3 levels in patients with stroke recovery stage were positively correlated with MMSE score (β=0.
    389, P<0.
    001; β=0.
    237, P=0.
    014).

    Result analysis and mechanism discussion The results of this study show: ①The age and NIHSS score of patients with cognitive impairment during stroke recovery were higher than those of the non-cognitive impairment group, and the levels of T3 and FT3 were lower than those of the non-cognitive impairment group ② The patient's serum T3 and FT3 levels were positively correlated with the MMSE score, suggesting that within the normal range, the lower the T3 and FT3 levels, the more severe the cognitive impairment.

     Based on a comprehensive analysis of experimental results and previous literature, the author found that stroke as a clinical stress event, on the one hand, causes hypothalamic-pituitary-thyroid axis dysfunction, which directly leads to the reduction of T3 and FT3 levels; on the other hand, a large number of literatures have found that T3 is The biological effect of the nervous system is higher than that of T4, and stroke can destroy the blood-brain barrier, reduce the level of organic anion transport polypeptides in epithelial cells, cause a decrease in T3 in the brain, and cause diffuse neurological dysfunction, which can cause cognitive impairment.

     In addition, areas such as the cerebral cortex and hippocampus are also the main areas where thyroid hormones play a biological role in the brain.
    Damage to these areas may inhibit the biological effects of thyroid hormones and further aggravate cognitive impairment.

     Based on experimental results, the author believes that the incidence of cognitive impairment in patients with stroke recovery is higher, and it is related to the reduction of thyroid hormones T3 and FT3.

    Therefore, thyroid hormone levels should be routinely tested during the recovery period of stroke, and cognitive function should be actively paid attention to, and comprehensive cognitive rehabilitation treatment measures should be given to patients as soon as possible.

    Article title: The lower the level of T3 and FT3, the more severe the cognitive impairment in stroke patients? Shijiazhuang People's Hospital published important correlation analysis 
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.